U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06874634) titled 'Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis' on March 11, 2024.
Brief Summary: Hypoalbuminemia has been shown to be significantly associated with increased mortality from abdominal sepsis, and early albumin infusion to maintain high serum albumin concentrations may be beneficial for the recovery of patients with abdominal sepsis. However, there have been no reports on whether administering albumin infusion can improve the prognosis, and there is no unified standard for the optimal serum albumin level for exogenous albumin infusion. This study aims to retrospectively collect patients with abdominal sepsis...